The National Agricultural Research Organisation (NARO) has signed an Assignment Agreement with Medical Research Centre (MRC) towards the patenting of a rapid wound healing technology. The end product which utilizes active ingredients in Zanthoxylum has anti-aging properties and is also considered a candidate for healing with cancer related ailments.
The partnership between NARO and MRC is as a result of a collaborative research that has been ongoing for the last two years under NARO’s Competitive Grants Scheme in accordance with Section 39 of the National Agricultural Research Act, 2005.
The two parties will hereafter jointly work towards the commercialization of the product. During the signing and exchange of documents, the Director General NARO Dr. Ambrose Agona reiterated NARO support towards private researchers to enable the Research Community make greater strides in the shortest time possible.
“To-date NARO has funded ninety 90 Private Research projects to the tune of Ushs 23 Billion under our Competitive Grants Scheme. Interested applicants are taken through a rigorous vetting exercise that ends with the best projects accessing funding to facilitate them. Medical Research Centre has been a beneficiary of this funding and we look forward to having the final product on the market shelves very soon.” Dr. Agona said
Prof. Evaristus Baruga on behalf of Medical Research Centre expressed his gratitude to NARO for the timely support at the time that it came through and committed to ensuring that the full commercial line of this drug is availed to the public in the shortest time possible.
